Capital International Investors Portfolio holdings
Capital International, established in 1968 as a division of the Los Angeles-based Capital Group, is a global investment management firm focused on delivering equity investment solutions for institutional and individual clients worldwide. Operating as part of one of the oldest and largest asset managers, founded in 1931, it leverages Capital Group’s signature research-driven, long-term investment philosophy, managing billions in assets through a multi-manager system that diversifies risk and enhances performance. Headquartered in Los Angeles with a presence across North America, Europe, and Asia, Capital International specializes in international and global equity strategies, often through mutual funds like those in the American Funds family. Known for its rigorous fundamental analysis and commitment to client outcomes, it plays a key role in Capital Group’s mission to provide consistent, superior returns in global markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amphenol
APH
|
+$1.61B |
| 2 |
Progressive
PGR
|
+$1.49B |
| 3 |
CGHM
Capital Group Municipal High-Income ETF
CGHM
|
+$1.44B |
| 4 |
Accenture
ACN
|
+$1.3B |
| 5 |
Gartner
IT
|
+$910M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.58B |
| 2 |
GE Vernova
GEV
|
+$1.45B |
| 3 |
Broadcom
AVGO
|
+$1.45B |
| 4 |
VICI Properties
VICI
|
+$1.39B |
| 5 |
Regeneron Pharmaceuticals
REGN
|
+$1.29B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.8% |
| 2 | Industrials | 12.85% |
| 3 | Financials | 12.29% |
| 4 | Communication Services | 10.98% |
| 5 | Consumer Discretionary | 9.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Aon
AON
$74.3B
| $626M | 0.1% |
1,756,457
+53,377
| +3% | +$19.3M |
|
152
ICICI Bank
IBN
$106B
| $614M | 0.1% |
20,309,980
-42,850
| -0.2% | -$1.4M |
|
|
153
VICI Properties
VICI
$29B
| $612M | 0.1% |
18,775,779
-42,095,190
| -69% | -$1.39B |
|
154
Ascendis Pharma A/S
ASND
$16.2B
| $608M | 0.1% |
3,060,616
+13,685
| +0.4% | +$2.55M |
|
155
Capital Group Dividend Growers ETF
CGDG
$5.62B
| $593M | 0.1% |
17,115,175
-235,678
| -1% | -$8.02M |
|
156
Walt Disney
DIS
$179B
| $589M | 0.1% |
5,148,071
+22,700
| +0.4% | +$2.67M |
|
157
Applovin
APP
$104B
| $587M | 0.09% |
816,561
+4,657
| +0.6% | +$2.15M |
|
158
OneMain Financial
OMF
$7.38B
| $586M | 0.09% |
10,376,590
+82,202
| +0.8% | +$4.85M |
|
159
Constellation Brands
STZ
$23.1B
| $584M | 0.09% |
4,337,054
+28,036
| +0.7% | +$4.46M |
|
|
KKR.PRD
160
KKR & Co 6.25% Series D Preferred Stock
KKR.PRD
$2.54B
| $583M | 0.09% |
11,144,300
+57,600
| +0.5% | +$3.23M |
|
161
TE Connectivity
TEL
$62.3B
| $576M | 0.09% |
2,626,754
+807,702
| +44% | +$162M |
|
162
CoStar Group
CSGP
$12.5B
| $573M | 0.09% |
6,788,554
-8,030,862
| -54% | -$710M |
|
163
Atlassian
TEAM
$39.4B
| $569M | 0.09% |
3,560,524
-71,990
| -2% | -$13M |
|
164
Fair Isaac
FICO
$22.8B
| $566M | 0.09% |
377,883
+302,734
| +403% | +$455M |
|
165
Equitable Holdings
EQH
$14.1B
| $559M | 0.09% |
11,012,837
+3,645,301
| +49% | +$193M |
|
166
PG&E
PCG
$39.1B
| $536M | 0.09% |
35,545,697
-12,884,953
| -27% | -$188M |
|
167
UL Solutions
ULS
$15.5B
| $535M | 0.09% |
7,548,311
+738,720
| +11% | +$50.3M |
|
168
Pinduoduo
PDD
$121B
| $514M | 0.08% |
3,891,319
+265,408
| +7% | +$31.4M |
|
169
Extra Space Storage
EXR
$31.4B
| $507M | 0.08% |
3,597,740
+35,752
| +1% | +$5.13M |
|
170
Capital Group Core Bond ETF
CGCB
$5.79B
| $505M | 0.08% |
19,008,607
+9,125,578
| +92% | +$241M |
|
171
Vale
VALE
$59B
| $502M | 0.08% |
46,215,387
+1,910,266
| +4% | +$19.5M |
|
172
Analog Devices
ADI
$189B
| $495M | 0.08% |
2,014,300
-308,137
| -13% | -$74.1M |
|
|
173
Regeneron Pharmaceuticals
REGN
$83.1B
| $493M | 0.08% |
876,564
-2,288,699
| -72% | -$1.29B |
|
174
Costco
COST
$421B
| $487M | 0.08% |
526,525
+8,940
| +2% | +$8.57M |
|
175
Trip.com Group
TCOM
$28.2B
| $480M | 0.08% |
6,379,206
+37,916
| +0.6% | +$2.53M |
|
Similar funds
Capital International Investors's Q3 2025 Portfolio in Review
As of Q3 2025, Capital International Investors held 472 positions worth $619B, up 6.7% from $581B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Capital International Investors's Q3 2025 filing shows 29 new, 218 increased, 160 reduced and 24 closed positions. Its largest new stake was Gartner: 3,119,843 shares worth $820M. The largest sale was Bristol-Myers Squibb, an estimated $1.58B.
By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 28% a quarter earlier, followed by Industrials and Financials.
- Capital International Investors's largest Q3 2025 buy was Gartner: 3,119,843 shares worth $820M.
- Capital International Investors added most to Amphenol in Q3 2025, an estimated $1.61B increase.
- Capital International Investors's biggest Q3 2025 reduction was Bristol-Myers Squibb, cutting an estimated $1.58B.
- Capital International Investors fully exited Eaton in Q3 2025, selling an estimated $607M.
- Capital International Investors's ten largest holdings make up 35% of its $619B portfolio in Q3 2025.
- Capital International Investors opened 29 new positions and closed 24 in Q3 2025.
- Capital International Investors's portfolio value rose 6.7% quarter-over-quarter to $619B.
Based on Capital International Investors's 13F filing for Q3 2025, filed 13 Nov 2025.